Coherus Biosciences | CHRS - Выручка от реализации

Биржевая цена
1.79
Изменение за день
0.08 4.39%
Ежемесячно
7.53%
Ежегодный
68.40%
Q2 прогноз
1.63




Продажи Изменить Дата
AbbVie USD 16.62B 840M 2025-12
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Akebia Therapeutics USD 57.62M 1.14M 2025-12
ALKERMES USD 384.5M 9.7M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.22M 451K 2025-12
Amgen USD 9.9B 340M 2025-12
Baxter International USD 2.97B 130M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Fujifilm JPY 857.35B 34.47B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
Merck USD 16.4B 880M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xencor USD 28.24M 7.24M 2025-12
Zoetis USD 2.4B 0 2025-12